- Home
- ROIV vs EXP Comparison
ROIV vs EXP Comparison
Compare ROIV & EXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- EXP
- Stock Information
- Founded
- ROIV 2014
- EXP 1963
- Country
- ROIV United Kingdom
- EXP United States
- Employees
- ROIV N/A
- EXP N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- EXP Building Materials
- Sector
- ROIV Health Care
- EXP Industrials
- Exchange
- ROIV Nasdaq
- EXP Nasdaq
- Market Cap
- ROIV 8.4B
- EXP 7.3B
- IPO Year
- ROIV N/A
- EXP 1994
- Fundamental
- Price
- ROIV $10.79
- EXP $240.02
- Analyst Decision
- ROIV Buy
- EXP Buy
- Analyst Count
- ROIV 4
- EXP 11
- Target Price
- ROIV $17.50
- EXP $275.45
- AVG Volume (30 Days)
- ROIV 5.9M
- EXP 278.7K
- Earning Date
- ROIV 05-29-2025
- EXP 05-20-2025
- Dividend Yield
- ROIV N/A
- EXP 0.42%
- EPS Growth
- ROIV N/A
- EXP N/A
- EPS
- ROIV N/A
- EXP 13.93
- Revenue
- ROIV $122,585,000.00
- EXP $2,267,040,000.00
- Revenue This Year
- ROIV N/A
- EXP $1.49
- Revenue Next Year
- ROIV N/A
- EXP $4.58
- P/E Ratio
- ROIV N/A
- EXP $17.20
- Revenue Growth
- ROIV 140.04
- EXP 0.64
- 52 Week Low
- ROIV $8.73
- EXP $201.61
- 52 Week High
- ROIV $13.06
- EXP $321.93
- Technical
- Relative Strength Index (RSI)
- ROIV 50.06
- EXP 61.02
- Support Level
- ROIV $10.58
- EXP $231.79
- Resistance Level
- ROIV $11.77
- EXP $241.89
- Average True Range (ATR)
- ROIV 0.34
- EXP 6.48
- MACD
- ROIV -0.07
- EXP 1.20
- Stochastic Oscillator
- ROIV 17.65
- EXP 92.51
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About EXP Eagle Materials Inc
Eagle Materials Inc produces and sells construction products and building materials. Construction products include cement, slag, concrete, and aggregates and building materials include cement and gypsum wallboard, and are sold to the construction and building industries. The firm organizes itself into two sectors: Heavy Materials, which includes the Cement and Concrete and Aggregates segments, and Light Materials, which includes the Gypsum Wallboard and Recycled Paperboard segments.